Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.
de Leeuw ALMP, Giralt J, Tao Y, Benavente S, Nguyen TF, Hoebers FJP, Hoeben A, Terhaard CHJ, Lee LW, Friesland S, Steenbakkers RJHM, Tans L, van Kranen SR, van de Kamer JB, Bartelink H, Rasch CRN, Sonke JJ, Hamming-Vrieze O.
de Leeuw ALMP, et al. Among authors: lee lw.
Radiother Oncol. 2025 Jan;202:110612. doi: 10.1016/j.radonc.2024.110612. Epub 2024 Nov 9.
Radiother Oncol. 2025.
PMID: 39522824
Clinical Trial.